Group Cognitive Behavioral Therapy (CBT) Intervention for Women With Mild to Moderate Depression

Depression Clinical Trial

— BackonTrack  

Official title:

A Pilot Study to Develop a Brief Group Intervention for Women With Mild and Moderate Depression

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00663078
• Other study ID #: 07/H0107/60
• Status: Completed
• Phase: Phase 0
• First received: April 18, 2008
• Last updated: January 13, 2010
• Start date: August 2007
• Est. completion date: March 2009

Study information

• Verified date: February 2009
• Source: University of Bristol
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Kingdom: Research Ethics Committee
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to develop a structured CBT group intervention for women with depression of mild or moderate severity and to pilot a randomized controlled trial to compare this intervention with usual care in socially deprived areas in Bristol, incorporating qualitative methods to assess acceptability.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: March 2009
• Est. primary completion date: March 2009
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 30 Years to 54 Years

Eligibility

Inclusion Criteria:

• mild to moderate depression

• antidepressant use is also OK

Exclusion Criteria:

• able to speak english

• abusing drugs or alcohol

• using secondary mental health services

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Anxiety
• Depression
• Depressive Disorder

Intervention

Behavioral:
• Brief CBT Group therapy
CBT based therapy also expert patient programme

Locations

Country	Name	City	State
United Kingdom	Merrywood GP Practice Knowle West,	Bristol
United Kingdom	Wellspring Healthy Living Centre	Bristol

Sponsors (1)

Lead Sponsor	Collaborator
University of Bristol

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PHQ-9 Score		3 months and 6 months	No